# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-11-091374
Filing Date
2011-04-07
Accepted
2011-04-07 17:11:40
Documents
11
Period of Report
2011-04-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d6k.htm | 6-K | 11973
2 | NOTICE OF ANNUAL GENERAL MEETING | dex991.htm | EX-99.1 | 6660
3 | MANAGEMENT INFORMATION CIRCULAR DATED MARCH 24, 2011 | dex992.htm | EX-99.2 | 367382
4 | FORM OF PROXY - ANNUAL GENERAL MEETING MAY 11, 2011 | dex993.htm | EX-99.3 | 13275
5 | PROXY VOTING FORM | dex994.htm | EX-99.4 | 17973
6 | GRAPHIC | g167472ex99_4pg001.jpg | GRAPHIC | 64005
7 | GRAPHIC | g167472ex99_4pg002.jpg | GRAPHIC | 63622
8 | GRAPHIC | g167472g02p71.jpg | GRAPHIC | 14055
9 | GRAPHIC | g167472g12h11.jpg | GRAPHIC | 180543
10 | GRAPHIC | g167472g53r95.jpg | GRAPHIC | 58425
11 | GRAPHIC | g167472g57f36.jpg | GRAPHIC | 133812
| Complete submission text file | 0001193125-11-091374.txt |  | 1128003

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 11746878
SIC: 2834 Pharmaceutical Preparations